Literature DB >> 25217187

Breastfeeding and migraine drugs.

Riccardo Davanzo1, Jenny Bua, Giulia Paloni, Giulia Facchina.   

Abstract

PURPOSE: Breastfeeding women may suffer from migraine. While we have many drugs for its treatment and prophylaxis, the majority are poorly studied in breastfeeding women. We conducted a review of the most common anti-migraine drugs (AMDs) and we determined their lactation risk.
METHODS: For each AMD, we collected all retrievable data from Hale's Medications and Mother Milk (2012), from the LactMed database (2014) of the National Library of Medicine, and from a MedLine Search of relevant studies published in the last 10 years.
RESULTS: According to our review, AMDs safe during breastfeeding are as follows: low-dose acetylsalicylic acid (ASA), ibuprofen, sumatriptan, metoprolol, propranolol, verapamil, amitriptyline, escitalopram, paroxetine, sertraline, acetaminophen, caffeine, and metoclopramide. AMDs compatible with breastfeeding but warranting caution are as follows: diclofenac, ketoprofen, naproxen, most new triptans, topiramate, valproate, venlafaxine, and cyproheptadine. Finally, high-dose ASA, atenolol, nadolol, cinnarizine, flunarizine, ergotamine, methysergide, and pizotifen are contraindicated.
CONCLUSIONS: According to our review, the majority of the revised AMDs were assessed to be compatible with breastfeeding.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25217187     DOI: 10.1007/s00228-014-1748-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  101 in total

Review 1.  Antidepressant drugs and breastfeeding: a review of the literature.

Authors:  Riccardo Davanzo; Marco Copertino; Angela De Cunto; Federico Minen; Alessandro Amaddeo
Journal:  Breastfeed Med       Date:  2010-10-19       Impact factor: 1.817

2.  Breastfeeding and the use of recreational drugs--alcohol, caffeine, nicotine and marijuana.

Authors:  J Liston
Journal:  Breastfeed Rev       Date:  1998-08

3.  Effect of ergonovine maleate on puerperal prolactin.

Authors:  J M Shane; F Naftolin
Journal:  Am J Obstet Gynecol       Date:  1974-09       Impact factor: 8.661

4.  Safety of triptans for migraine headaches during pregnancy and breastfeeding.

Authors:  Silvia Duong; Pina Bozzo; Hedvig Nordeng; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2010-06       Impact factor: 3.275

5.  Hyperprolactinemia-galactorrhea induced by verapamil.

Authors:  E L Fearrington; C H Rand; J D Rose
Journal:  Am J Cardiol       Date:  1983-05-01       Impact factor: 2.778

6.  Effects of breastfeeding in children of women taking antiepileptic drugs.

Authors:  K J Meador; G A Baker; N Browning; J Clayton-Smith; D T Combs-Cantrell; M Cohen; L A Kalayjian; A Kanner; J D Liporace; P B Pennell; M Privitera; D W Loring
Journal:  Neurology       Date:  2010-11-24       Impact factor: 9.910

7.  Passage of paracetamol into breast milk and its subsequent metabolism by the neonate.

Authors:  L J Notarianni; H G Oldham; P N Bennett
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

8.  Atenolol and metoprolol. A comparison of their excretion into human breast milk.

Authors:  J Kulas; N O Lunell; U Rosing; B Stéen; A Rane
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1984

9.  Effect of maternal caffeine consumption on heart rate and sleep time of breast-fed infants.

Authors:  J E Ryu
Journal:  Dev Pharmacol Ther       Date:  1985

10.  Antiepileptic drugs and breastfeeding.

Authors:  Riccardo Davanzo; Sara Dal Bo; Jenny Bua; Marco Copertino; Elisa Zanelli; Lorenza Matarazzo
Journal:  Ital J Pediatr       Date:  2013-08-28       Impact factor: 2.638

View more
  8 in total

Review 1.  Women and Migraine: the Role of Hormones.

Authors:  Candice Todd; Ana Marissa Lagman-Bartolome; Christine Lay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-31       Impact factor: 5.081

Review 2.  Pharmacological treatment of migraine during pregnancy and breastfeeding.

Authors:  Siri Amundsen; Hedvig Nordeng; Kateřina Nezvalová-Henriksen; Lars Jacob Stovner; Olav Spigset
Journal:  Nat Rev Neurol       Date:  2015-04       Impact factor: 42.937

Review 3.  Valproic Acid in Women and Girls of Childbearing Age.

Authors:  Dorothy Gotlib; Rachel Ramaswamy; Jacob E Kurlander; Alana DeRiggi; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2017-09       Impact factor: 5.285

Review 4.  Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing.

Authors:  Irving Zucker
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

5.  Codeine Precipitating Serotonin Syndrome in a Patient in Therapy with Antidepressant and Triptan.

Authors:  Giulia Milano; Werner Maria Natta; Alfredo Bello; Antonietta Martelli; Francesca Mattioli
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-08-31       Impact factor: 2.582

6.  Paroxetine increases delta opioid responsiveness in sensory neurons.

Authors:  Allison Doyle Brackley; Nathaniel A Jeske
Journal:  eNeuro       Date:  2022-07-25

7.  KCNQ1 and Long QT Syndrome in 1/45 Amish: The Road From Identification to Implementation of Culturally Appropriate Precision Medicine.

Authors:  Elizabeth A Streeten; Vincent Y See; Linda B J Jeng; Kristin A Maloney; Megan Lynch; Andrew M Glazer; Tao Yang; Dan Roden; Toni I Pollin; Melanie Daue; Kathleen A Ryan; Cristopher Van Hout; Nehal Gosalia; Claudia Gonzaga-Jauregui; Aris Economides; James A Perry; Jeffrey O'Connell; Amber Beitelshees; Kathleen Palmer; Braxton D Mitchell; Alan R Shuldiner
Journal:  Circ Genom Precis Med       Date:  2020-11-03

Review 8.  A narrative review of the importance of pharmacokinetics and drug-drug interactions of preventive therapies in migraine management.

Authors:  Shivang Joshi; Stewart J Tepper; Sylvia Lucas; Soeren Rasmussen; Rob Nelson
Journal:  Headache       Date:  2021-06       Impact factor: 5.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.